Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice? ; volume:10 ; number:5 ; day:10 ; month:7 ; year:2019 ; pages:1625-1643 ; date:10.2019
Diabetes therapy ; 10, Heft 5 (10.7.2019), 1625-1643, 10.2019
- Creator
-
Deed, Gary
Atherton, John J.
d’Emden, Michael
Rasalam, Roy
Sharma, Anita
Sindone, Andrew
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-019-0663-x
- URN
-
urn:nbn:de:101:1-2020021310463856926645
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Deed, Gary
- Atherton, John J.
- d’Emden, Michael
- Rasalam, Roy
- Sharma, Anita
- Sindone, Andrew
- SpringerLink (Online service)
Other Objects (12)
Updates on cardiovascular outcome trials in diabetes
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
Adaptive designs for clinical trials in cardiovascular diseases
Current perspectives on cardiovascular outcome trials in diabetes
Patients’ experiences managing cardiovascular disease and risk factors in prison
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
Managing clinical trials
Correction to: Updates on cardiovascular outcome trials in diabetes
Cardiovascular outcome trials of glucose-lowering medications: an update
PDM-ProValue meets cardiovascular outcome trials in diabetes
Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis
Updates on cardiovascular outcome trials in diabetes
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
Adaptive designs for clinical trials in cardiovascular diseases
Current perspectives on cardiovascular outcome trials in diabetes
Patients’ experiences managing cardiovascular disease and risk factors in prison
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
Managing clinical trials
Correction to: Updates on cardiovascular outcome trials in diabetes
Cardiovascular outcome trials of glucose-lowering medications: an update
PDM-ProValue meets cardiovascular outcome trials in diabetes
Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis
Updates on cardiovascular outcome trials in diabetes
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
Adaptive designs for clinical trials in cardiovascular diseases
Current perspectives on cardiovascular outcome trials in diabetes
Patients’ experiences managing cardiovascular disease and risk factors in prison
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
Managing clinical trials
Correction to: Updates on cardiovascular outcome trials in diabetes
Cardiovascular outcome trials of glucose-lowering medications: an update
PDM-ProValue meets cardiovascular outcome trials in diabetes